CA2413923A1 - Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin metronidazole and a gastrointestinal hydrogen pump inhibitor - Google Patents

Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin metronidazole and a gastrointestinal hydrogen pump inhibitor Download PDF

Info

Publication number
CA2413923A1
CA2413923A1 CA002413923A CA2413923A CA2413923A1 CA 2413923 A1 CA2413923 A1 CA 2413923A1 CA 002413923 A CA002413923 A CA 002413923A CA 2413923 A CA2413923 A CA 2413923A CA 2413923 A1 CA2413923 A1 CA 2413923A1
Authority
CA
Canada
Prior art keywords
analogue
derivative
use according
metronidazole
erythromycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002413923A
Other languages
English (en)
French (fr)
Inventor
Andrew Ilchyshyn
Ian Andrew Whitecroft
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00301951A external-priority patent/EP1133987A1/de
Application filed by Individual filed Critical Individual
Publication of CA2413923A1 publication Critical patent/CA2413923A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002413923A 2000-03-09 2001-03-09 Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin metronidazole and a gastrointestinal hydrogen pump inhibitor Abandoned CA2413923A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP00301951.0 2000-03-09
EP00301951A EP1133987A1 (de) 2000-03-09 2000-03-09 Behandlung von entzündlichen Dermatosen mit Erythromycin oder Clarithromycin, Metronidazol und einem Wasserstoffpumpehemmer
US18896100P 2000-03-10 2000-03-10
US60/188,961 2000-03-10
PCT/GB2001/001047 WO2001066117A1 (en) 2000-03-09 2001-03-09 Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin metronidazole and a gastrointestinal hydrogen pump inhibitor

Publications (1)

Publication Number Publication Date
CA2413923A1 true CA2413923A1 (en) 2001-09-13

Family

ID=26073033

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002413923A Abandoned CA2413923A1 (en) 2000-03-09 2001-03-09 Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin metronidazole and a gastrointestinal hydrogen pump inhibitor

Country Status (4)

Country Link
EP (1) EP1263445A1 (de)
AU (1) AU3762801A (de)
CA (1) CA2413923A1 (de)
WO (1) WO2001066117A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003049716A1 (en) * 2001-12-13 2003-06-19 Ranbaxy Laboratories Limited Stable topical formulation of clarithromycin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
IS3990A (is) * 1992-04-24 1993-10-25 Ab Astra Aðferð við að blanda saman efni sem hindrar flæðimagasýru og bakteríueyðandi efnis sem brotnar niður í súru umhverfi
CA2180535C (en) * 1994-01-05 2004-03-23 Lindberg, Per Lennart A method for treatment of psoriasis, by omeprazole or related compounds
BR9508261A (pt) * 1994-07-08 1997-12-23 Astra Ab Formulação oral entericamente revestida uso da mesma processo para preparer a formulação inibir a secreção de ácido gástrico em mamíferos e no ser humano e tratar doenças relacionadas ao ácido gástrico em maníferos e no ser humano e pacote de empola de pressão transversal
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
JPH10158172A (ja) * 1996-11-29 1998-06-16 Takeshi Azuma 肝性脳症治療剤又は肝性脳症予防剤
US6017950A (en) * 1997-08-05 2000-01-25 Millennium Pharmaceuticals, Inc. Methods for controlling gram negative bacteria in mammals
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components

Also Published As

Publication number Publication date
WO2001066117A1 (en) 2001-09-13
EP1263445A1 (de) 2002-12-11
AU3762801A (en) 2001-09-17

Similar Documents

Publication Publication Date Title
Mehrabi et al. Therapeutic agents in perioperative third molar surgical procedures
US20180264021A1 (en) Treatment of papulopustular rosacea with ivermectin
ES2389539T3 (es) Métodos y composiciones para el tratamiento del asma
CN105362286A (zh) 用于治疗哺乳动物的内和外耳感染的耳用组合物
Mays et al. New antibiotic therapies for acne and rosacea
US9125927B2 (en) Compositions comprising avermectin/azelaic acid compounds useful for treating, e.g., rosacea
Graziani et al. Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction
US20110178049A1 (en) Avermectin/hydrocortisone compositions for treating afflictions of the skin. e.g., rosacea
JP2009514963A (ja) 肉芽腫性酒さの治療ためのアジスロマイシン
CA2896578A1 (en) Carrier and pharmaceutical compositions for intrasinal delivery and uses thereof
JP6775869B2 (ja) ピリドンカルボン酸系誘導体を含有する外用剤
CA2413923A1 (en) Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin metronidazole and a gastrointestinal hydrogen pump inhibitor
EP1133987A1 (de) Behandlung von entzündlichen Dermatosen mit Erythromycin oder Clarithromycin, Metronidazol und einem Wasserstoffpumpehemmer
US10328094B2 (en) Compound from the avermectin family for treating and/or preventing folliculitis
EP3664786B1 (de) Verfahren zur behandlung des schnitzler-syndroms
WO2016121147A1 (ja) 注腸剤
TW202106690A (zh) 皮膚型紅斑狼瘡之治療
ITTO950607A1 (it) Composizione farmaceutica per uso topico
US9782425B2 (en) Treatment of papulopustular rosacea with ivermectin
US11903992B2 (en) Composition comprising lidocaine, l-carnosine and dexpanthenol
KR20170099911A (ko) 파라세타몰 주사 제제
Rebora et al. Papulopustular rosacea
Diehl New Insights into Rosacea. Part II. Treatment
BR112018012195B1 (pt) Uso de 2-[4-(1,1-dimetiletil)fenil]-1h-benzimidazol, ou um sal farmaceuticamente aceitável do mesmo
Yosef et al. ACUTE RHINOSINUSITIS: NASONEX AS ADJUNCTIVE THERAPY

Legal Events

Date Code Title Description
FZDE Discontinued